Jane Street’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$898K Buy
393,700
+382,100
+3,294% +$880K ﹤0.01% 6752
2025
Q4
$32.5K Sell
11,600
-5,800
-33% -$20.7K ﹤0.01% 10630
2025
Q3
$83.5K Buy
+17,400
New +$111K ﹤0.01% 10208
2025
Q2
Sell
-11,300
Closed -$102K 10503
2025
Q1
$102K Buy
+11,300
New +$119K ﹤0.01% 8797
2024
Q2
Sell
-522,400
Closed -$14.5M 9963
2024
Q1
$14.5M Buy
+522,400
New +$11.6M ﹤0.01% 1463
2023
Q1
Sell
-27,600
Closed -$539K 9672
2022
Q4
$539K Sell
27,600
-4,600
-14% -$89.7K ﹤0.01% 5997
2022
Q3
$776K Sell
32,200
-24,100
-43% -$743K ﹤0.01% 5887
2022
Q2
$1.77M Buy
56,300
+13,100
+30% +$475K ﹤0.01% 4387
2022
Q1
$1.9M Buy
43,200
+21,700
+101% +$932K ﹤0.01% 4854
2021
Q4
$935K Buy
21,500
+3,600
+20% +$141K ﹤0.01% 6025
2021
Q3
$560K Sell
17,900
-17,400
-49% -$685K ﹤0.01% 7075
2021
Q2
$1.49M Buy
35,300
+10,000
+40% +$389K ﹤0.01% 4940
2021
Q1
$951K Sell
25,300
-103,200
-80% -$3.23M ﹤0.01% 5546
2020
Q4
$3.48M Sell
128,500
-24,500
-16% -$630K ﹤0.01% 2608
2020
Q3
$3.84M Buy
153,000
+46,700
+44% +$681K ﹤0.01% 2152
2020
Q2
$810K Sell
106,300
-233,700
-69% -$1.71M ﹤0.01% 4376
2020
Q1
$3.11M Buy
+340,000
New +$2.05M ﹤0.01% 1589

Other funds holding ACH

Jane Street's ACH Position: Q1 2026 in Review

Jane Street sold out of Accendra Health (ACH) in Q1 2026, closing a stake of 1,070,909 shares — an estimated $2.47M sold.

Jane Street first reported a position in ACH in Q2 2013 and held it in 28 quarters. The position peaked at $6.4M in Q3 2025. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

  • Jane Street reported no remaining Accendra Health position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 1,070,909 Accendra Health shares in Q1 2026, an estimated $2.47M.
  • Jane Street first reported a position in Accendra Health in Q2 2013 and held it in 28 quarters.
  • Jane Street's Accendra Health position peaked at $6.4M in Q3 2025.
  • 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.